Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem

Abstract Liver cancer is one of the most common malignancies worldwide. The RAF kinase inhibitors are effective in the treatment of hepatocellular carcinoma (HCC); therefore, inhibition of the BRAF/MEK/ERK pathway has become a new therapeutic strategy for novel HCC therapy. However, targeted specifi...

Full description

Bibliographic Details
Main Authors: Yanling Liu, Manman Tan, Yujuan Zhang, Wei Huang, Liangliang Min, Shanshan Peng, Keng Yuan, Li Qiu, Weiping Min
Format: Article
Language:English
Published: SpringerOpen 2020-05-01
Series:Nanoscale Research Letters
Subjects:
Online Access:http://link.springer.com/article/10.1186/s11671-020-03340-x
_version_ 1797728300567625728
author Yanling Liu
Manman Tan
Yujuan Zhang
Wei Huang
Liangliang Min
Shanshan Peng
Keng Yuan
Li Qiu
Weiping Min
author_facet Yanling Liu
Manman Tan
Yujuan Zhang
Wei Huang
Liangliang Min
Shanshan Peng
Keng Yuan
Li Qiu
Weiping Min
author_sort Yanling Liu
collection DOAJ
description Abstract Liver cancer is one of the most common malignancies worldwide. The RAF kinase inhibitors are effective in the treatment of hepatocellular carcinoma (HCC); therefore, inhibition of the BRAF/MEK/ERK pathway has become a new therapeutic strategy for novel HCC therapy. However, targeted specific delivery systems for tumors are still significant obstacle to clinical applications. Galactose (GAL) can target the asialoglycoprotein receptor (ASGPR) that is highly expressed on liver cancer cells. In this study, we designed a novel multifunctional nanomaterial GAL-GNR-siBRAF which consists of three parts, GAL as the liver cancer-targeting moiety, golden nanorods (GNR) offering photothermal capability under near infrared light, and siRNA specifically silencing BRAF (siBRAF). The nanocarrier GAL-GNR-siBRAF showed high siRNA loading capacity and inhibited the degradation of siRNA in serum. Compared with naked gold nanorods, GAL-GNR-siBRAF possessed lower biotoxicity and higher efficacy of gene silencing. Treatment with GAL-GNR-siBRAF significantly downregulated the expression of BRAF and impaired proliferation, migration, and invasion of liver cancer cells. Moreover, combinatorial photothermal effects and BRAF knockdown by GAL-GNR-siBRAF effectively given rise to tumor cell death. Therefore, our study developed a new type of targeted multi-functional nanomaterial GAL-GNR-siBRAF for the treatment of liver cancer, which provides ideas for the development of new clinical treatment methods.
first_indexed 2024-03-12T11:12:02Z
format Article
id doaj.art-d36b9d21b1da4671bd3b8f61879b592e
institution Directory Open Access Journal
issn 1556-276X
language English
last_indexed 2024-03-12T11:12:02Z
publishDate 2020-05-01
publisher SpringerOpen
record_format Article
series Nanoscale Research Letters
spelling doaj.art-d36b9d21b1da4671bd3b8f61879b592e2023-09-02T02:49:05ZengSpringerOpenNanoscale Research Letters1556-276X2020-05-0115111210.1186/s11671-020-03340-xTargeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF NanosystemYanling Liu0Manman Tan1Yujuan Zhang2Wei Huang3Liangliang Min4Shanshan Peng5Keng Yuan6Li Qiu7Weiping Min8Institute of Immunotherapy, Nanchang UniversityInstitute of Immunotherapy, Nanchang UniversityInstitute of Immunotherapy, Nanchang UniversityInstitute of Immunotherapy, Nanchang UniversityInstitute of Immunotherapy, Nanchang UniversityJiangxi Institute of Medical Sciences NanchangJiangxi Institute of Medical Sciences NanchangDepartment of Endocrinology and Metabolism, Peking University People’s HospitalInstitute of Immunotherapy, Nanchang UniversityAbstract Liver cancer is one of the most common malignancies worldwide. The RAF kinase inhibitors are effective in the treatment of hepatocellular carcinoma (HCC); therefore, inhibition of the BRAF/MEK/ERK pathway has become a new therapeutic strategy for novel HCC therapy. However, targeted specific delivery systems for tumors are still significant obstacle to clinical applications. Galactose (GAL) can target the asialoglycoprotein receptor (ASGPR) that is highly expressed on liver cancer cells. In this study, we designed a novel multifunctional nanomaterial GAL-GNR-siBRAF which consists of three parts, GAL as the liver cancer-targeting moiety, golden nanorods (GNR) offering photothermal capability under near infrared light, and siRNA specifically silencing BRAF (siBRAF). The nanocarrier GAL-GNR-siBRAF showed high siRNA loading capacity and inhibited the degradation of siRNA in serum. Compared with naked gold nanorods, GAL-GNR-siBRAF possessed lower biotoxicity and higher efficacy of gene silencing. Treatment with GAL-GNR-siBRAF significantly downregulated the expression of BRAF and impaired proliferation, migration, and invasion of liver cancer cells. Moreover, combinatorial photothermal effects and BRAF knockdown by GAL-GNR-siBRAF effectively given rise to tumor cell death. Therefore, our study developed a new type of targeted multi-functional nanomaterial GAL-GNR-siBRAF for the treatment of liver cancer, which provides ideas for the development of new clinical treatment methods.http://link.springer.com/article/10.1186/s11671-020-03340-xGold nanorodsBRAFsiRNALiver cancerGalactose
spellingShingle Yanling Liu
Manman Tan
Yujuan Zhang
Wei Huang
Liangliang Min
Shanshan Peng
Keng Yuan
Li Qiu
Weiping Min
Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
Nanoscale Research Letters
Gold nanorods
BRAF
siRNA
Liver cancer
Galactose
title Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
title_full Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
title_fullStr Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
title_full_unstemmed Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
title_short Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
title_sort targeted gene silencing braf synergized photothermal effect inhibits hepatoma cell growth using new gal gnr sibraf nanosystem
topic Gold nanorods
BRAF
siRNA
Liver cancer
Galactose
url http://link.springer.com/article/10.1186/s11671-020-03340-x
work_keys_str_mv AT yanlingliu targetedgenesilencingbrafsynergizedphotothermaleffectinhibitshepatomacellgrowthusingnewgalgnrsibrafnanosystem
AT manmantan targetedgenesilencingbrafsynergizedphotothermaleffectinhibitshepatomacellgrowthusingnewgalgnrsibrafnanosystem
AT yujuanzhang targetedgenesilencingbrafsynergizedphotothermaleffectinhibitshepatomacellgrowthusingnewgalgnrsibrafnanosystem
AT weihuang targetedgenesilencingbrafsynergizedphotothermaleffectinhibitshepatomacellgrowthusingnewgalgnrsibrafnanosystem
AT liangliangmin targetedgenesilencingbrafsynergizedphotothermaleffectinhibitshepatomacellgrowthusingnewgalgnrsibrafnanosystem
AT shanshanpeng targetedgenesilencingbrafsynergizedphotothermaleffectinhibitshepatomacellgrowthusingnewgalgnrsibrafnanosystem
AT kengyuan targetedgenesilencingbrafsynergizedphotothermaleffectinhibitshepatomacellgrowthusingnewgalgnrsibrafnanosystem
AT liqiu targetedgenesilencingbrafsynergizedphotothermaleffectinhibitshepatomacellgrowthusingnewgalgnrsibrafnanosystem
AT weipingmin targetedgenesilencingbrafsynergizedphotothermaleffectinhibitshepatomacellgrowthusingnewgalgnrsibrafnanosystem